Clinical Trial Update: Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Lenalidomide, Bortezomib, and Dexamethasone for multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-03-13